Bluejay Therapeutics Stock
Bluejay Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, with a primary focus on hepatitis B. Founded to address unmet medical needs, the company leverages advanced technologies to create effective and accessible treatments.
Founded: 2019
Management Team
| Keting Chu Founder and Chief Executive Officer |
| Hassan Javanbakht Chief Scientific Officer |
| Nancy Shulman Chief Medical Officer |
